Department of General Internal Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Section of Education for Clinical Research, Kyoto University Hospital, Kyoto, Japan.
J Glob Antimicrob Resist. 2022 Sep;30:348-353. doi: 10.1016/j.jgar.2022.06.010. Epub 2022 Jun 19.
The clinical evidence for the effect of narrow-spectrum antimicrobial shortages on bacterial susceptibility is limited. Our purposes were to determine the affects of the disruption of most of the cefazolin (CEZ) supply in Japan on the susceptibility of pathogens and to analyze how long these changes persisted after the shortage of CEZ.
We performed an interrupted time series analysis using the Japanese Infectious Disease Nationwide database. We analyzed each pathogen before and after CEZ shortage in 52 university hospitals from 2018 to 2020. May to November 2019 was designated as the implementation term for CEZ shortage. The primary outcome was the susceptibility to CEZ and other antimicrobial agents. Amongst all pathogens isolated from facilities, we identified pathogens that were tested for susceptibility to CEZ.
Of the 26 pathogens identified, analysis was performed on a total of 36,346 isolates of five pathogens (Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis, and Staphylococcus aureus). Amongst four Gram-negative pathogens with low susceptibility, there were no significant immediate changes after the CEZ shortage; however, the slope change significantly increased by 1.29 to 2.69% per month and continued to improve one year after the shortage. Regarding S. aureus, which was highly susceptible at the baseline, neither immediate change nor slope was significant.
This quasi-experimental analysis using a nationwide-large database revealed that restriction of use because of narrow-spectrum antimicrobial shortages may lead to improved susceptibility over the subsequent year. The results suggest that temporary switching of antimicrobial agents on a national scale could be effective.
窄谱抗菌药物短缺对细菌敏感性的临床证据有限。我们的目的是确定日本大部分头孢唑林(CEZ)供应中断对病原体敏感性的影响,并分析 CEZ 短缺后这些变化持续的时间。
我们使用日本传染病全国数据库进行了一项中断时间序列分析。我们分析了 2018 年至 2020 年 52 所大学医院在 CEZ 短缺前后的每一种病原体。2019 年 5 月至 11 月被指定为 CEZ 短缺的实施期。主要结局是对 CEZ 和其他抗菌药物的敏感性。在从医疗机构分离出的所有病原体中,我们确定了对 CEZ 敏感性进行测试的病原体。
在所确定的 26 种病原体中,对五种病原体(大肠埃希菌、肺炎克雷伯菌、产酸克雷伯菌、奇异变形杆菌和金黄色葡萄球菌)的 36346 株总分离株进行了分析。在四种敏感性较低的革兰氏阴性病原体中,CEZ 短缺后没有立即发生显著变化;然而,斜率变化每月显著增加 1.29%至 2.69%,并在短缺一年后持续改善。对于基线高度敏感的金黄色葡萄球菌,无论是即时变化还是斜率都不显著。
这项使用全国性大型数据库的准实验分析表明,由于窄谱抗菌药物短缺而限制使用可能会导致随后一年敏感性提高。结果表明,在全国范围内临时切换抗菌药物可能是有效的。